Literature DB >> 4260121

The electrophysiologic effects of low and high digoxin concentrations on isolated mammalian cardiac tissue: reversal by digoxin-specific antibody.

W J Mandel, J T Bigger, V P Butler.   

Abstract

The effects of digoxin on electrophysiologic properties were evaluated in isolated perfused cardiac tissue. In canine Purkinje fiber (PF)-ventricular muscle (VM) preparations, control measurements, using microelectrode technique, were made of: resting potential (RP), action potential (AP) amplitude, rate of rise, overshoot, duration (APD), membrane responsiveness, conduction velocity (CV), and refractory period. The preparation was then exposed to 1 x 10(-7) M digoxin and repeat measurements were carried out every 15 min. At slow (30/min) rates of stimulation APD initially prolonged then markedly shortened. With more rapid stimulation (75 and 120/min) no initial APD prolongation was observed. When stimulated at 75/min, RP and AP rate of rise, amplitude, and CV remained near control values for 60-75 min then rapidly decreased until electrical inexcitability (110+/-15 min). At that time fibers were perfused with serum containing digoxin-specific antibody (DSA) or one of a group of test solutions. In the preparations exposed to DSA, membrane characteristics improved by 15 min, and by 60 min approximated control values. No beneficial effect was seen with the various test solutions. DSA also reversed digoxin-induced enhanced phase 4 depolarization in PF. Effective (ERP) and Functional (FRP) refractory periods of rabbit atrioventricular (AV) node preparations were measured in the control state. The tissue was then exposed to 1 x 10(-7) M digoxin and refractory period measurements repeated. At a time when AV conduction prolonged by 20%, associated with marked prolongation of ERP and FRP, DSA or various test solutions were perfused. The prolongation in ERP, FRP, and AV conduction time rapidly returned to normal only in the DSA perfused tissue. It is concluded that DSA has the ability to reverse pronounced toxic electrophysiological effects of digoxin in in vitro cardiac tissue.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4260121      PMCID: PMC292274          DOI: 10.1172/JCI106933

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

Review 1.  EFFECT OF DIGITALIS ON CONDUCTION OF THE HEART.

Authors:  C FISCH; K GREENSPAN; S B KNOEBEL; H FEIGENBAUM
Journal:  Prog Cardiovasc Dis       Date:  1964-01       Impact factor: 8.194

2.  The effect of the cardiac membrane potential on the rapid availability of the sodium-carrying system.

Authors:  S WEIDMANN
Journal:  J Physiol       Date:  1955-01-28       Impact factor: 5.182

3.  Toxic effects of ouabain on Purkinje fibers and ventricular muscle fibers.

Authors:  M VASSALLE; J KARIS; B F HOFFMAN
Journal:  Am J Physiol       Date:  1962-09

4.  The action of several cardiac glycosides on conduction velocity and ventricular excitability in the dog heart.

Authors:  G K MOE; R MENDEZ
Journal:  Circulation       Date:  1951-11       Impact factor: 29.690

5.  The normal membrane potential of frog sartorius fibers.

Authors:  G LING; R W GERARD
Journal:  J Cell Comp Physiol       Date:  1949-12

6.  Digoxin-specific antibodies.

Authors:  V P Butler; J P Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1967-01       Impact factor: 11.205

7.  Correlation of cardiac sodium- and potassium-activated adenosine triphosphatase activity with ouabain-induced inotropic stimulation.

Authors:  T Akera; F S Larsen; T M Brody
Journal:  J Pharmacol Exp Ther       Date:  1970-05       Impact factor: 4.030

8.  On the mechanism of ouabain toxicity in Purkinje and ventricular muscle fibers at rest and during activity.

Authors:  P I Polimeni; M Vassalle
Journal:  Am J Cardiol       Date:  1971-06       Impact factor: 2.778

9.  Effect of lidocaine on conduction in canine Purkinje fibers and at the ventricular muscle-Purkinje fiber junction.

Authors:  J T Bigger; W J Mandel
Journal:  J Pharmacol Exp Ther       Date:  1970-04       Impact factor: 4.030

10.  Electrophysiologic effects of digitalis on A-V transmission.

Authors:  Y Watanabe; L S Dreifus
Journal:  Am J Physiol       Date:  1966-12
View more
  7 in total

1.  Reversal of advanced digitoxin toxicity and modification of pharmacokinetics by specific antibodies and Fab fragments.

Authors:  H R Ochs; T W Smith
Journal:  J Clin Invest       Date:  1977-12       Impact factor: 14.808

2.  The electrophysiological effects of ouabain on sinus node and atrium in man.

Authors:  R C Dhingra; F Amat-Y-Leon; C Wyndham; D Wu; P Denes; K M Rosen
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  The influence of digoxin antibodies on digoxin disposition and effect: studies in guinea-pigs and HeLa cells.

Authors:  N M Griffiths; D S Hewick; J F Lamb; I H Stevenson
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

4.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

5.  Extracellular versus intracellular digoxin action on bovine myocardium, using a digoxin antibody and intracellular glycoside application.

Authors:  P Hess; P Müller
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

6.  Effects of digoxin-specific antibodies on accumulation and binding of digoxin by human erythrocytes.

Authors:  J D Gardner; D R Kilno; T J Swartz; V P Butler
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

7.  Reversal of ouabain and acetyl strophanthidin effects in normal and failing cardiac muscle by specific antibody.

Authors:  H K Gold; T W Smith
Journal:  J Clin Invest       Date:  1974-06       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.